Renaissance Group LLC Sells 85,712 Shares of HCA Healthcare, Inc. $HCA

Renaissance Group LLC trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 93.1% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 6,334 shares of the company’s stock after selling 85,712 shares during the quarter. Renaissance Group LLC’s holdings in HCA Healthcare were worth $2,700,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Clearstead Trust LLC increased its stake in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after buying an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. increased its position in HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after acquiring an additional 34 shares in the last quarter. Twin Peaks Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the second quarter worth approximately $40,000. Compound Global Advisors LLC bought a new position in HCA Healthcare in the 3rd quarter worth approximately $44,000. Finally, True Wealth Design LLC boosted its position in HCA Healthcare by 179.5% in the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock valued at $47,000 after buying an additional 70 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the topic of several recent research reports. Wall Street Zen upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. Zacks Research cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, January 28th. Raymond James Financial set a $525.00 price target on HCA Healthcare in a research report on Monday, October 27th. Finally, Royal Bank Of Canada increased their target price on HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $521.55.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,500 shares of HCA Healthcare stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the sale, the executive vice president owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is owned by insiders.

HCA Healthcare Trading Down 2.3%

NYSE:HCA opened at $501.89 on Friday. The stock has a market cap of $114.53 billion, a price-to-earnings ratio of 17.68, a PEG ratio of 1.54 and a beta of 1.36. The stock has a 50-day moving average price of $479.97 and a two-hundred day moving average price of $442.72. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $527.55.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same period last year, the business posted $6.22 earnings per share. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is presently 10.99%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.